Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Cephalon/North American Vaccine

Executive Summary

Cephalon/North American Vaccine: $25 mil. definitive agreement for North American Vaccine to acquire Cephalon's Beltsville, Md. pharmaceutical manufacturing facility is announced Oct. 18. North American Vaccine will manufacture conjugate polysaccharide pneumococcal, group b streptococcus, and meningococcal vaccines at the Beltsville facility. Cephalon will manufacture Myotrophin in Chiron's recently completed facility in Vacaville, Calif. The company plans to file an NDA before the end of the year without an additional study...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts